Alcohol Abuse and Cancer

CME credit is no longer available for this conference.

Danilo De Gregorio, PharmD, Ph.D.

Dr. De Gregorio is Associate Professor of Pharmacology, Division of Neuroscience, Vita-Salute San Raffaele University, Milan, Italy.

Within the past 12 months, Dr. De Gregorio has been a consultant to Diamond Therapeutics Inc., Toronto, Canada.

Release Date: 01/06/2025

Upon completion of this Cyberounds^®, you should be able to:

Discuss the pathophysiological mechanisms linking alcohol use disorder and cancer development;
Identify the specific types of cancer most strongly associated with chronic alcohol consumption;
Describe effective clinical strategies for managing patients with comorbid alcohol use disorder and cancer.

Several investigational agents offer hope to patients with AML.

Authors: Mary-Elizabeth M. Percival, M.D., M.S. and Roland B. Walter, M.D., Ph.D., M.S.

While some disorders are more readily apparent than others, not all bleeding is straightforward or has a readily identifiable cause.

Authors: Meera B. Chitlur, M.D.

Despite advances in lung cancer chemotherapy, there is a pressing need for effective lung cancer chemoprevention beyond smoking cessation.

Authors: Robert L. Keith, M.D.

Neuro−oncology is focusing on the uses of molecularly targeted agents in the adjuvant setting.

Authors: Nicole A. Shonka, M.D., and Mark R. Gilbert, M.D.

AML2